Hyundai Pharm (004310) — Cash Flow Reinvestment Rate
Hyundai Pharm (004310) has a Cash Flow Reinvestment Rate of 5.06x as of May 2026, reinvesting ₩12.10 Billion (capex ₩1.09 Billion plus investments ₩-11.01 Billion) from operating cash flow of ₩2.39 Billion. See Hyundai Pharm (004310) free cash flow to measure how efficiently the company converts operating cash flow to free cash.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Hyundai Pharm Cash Flow Reinvestment Rate (2010–2022)
Historical reinvestment intensity for Hyundai Pharm across 8 annual periods. For the full cash flow conversion analysis, see 004310 cash flow metrics.
Annual Cash Flow Reinvestment Rate for Hyundai Pharm (2010–2022)
Year-by-year capital reinvestment analysis for Hyundai Pharm. See Hyundai Pharm (004310) financial flexibility to measure the company's free cash flow as a share of total liabilities.
| Year | Reinvestment Rate | Total Reinvested (KRW) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2022 | 1.43x | ₩16.57 Billion | ₩11.62 Billion | ₩6.58 Billion | ▲ +7.0% |
| 2021 | 1.33x | ₩6.84 Billion | ₩5.13 Billion | ₩6.81 Billion | ▼ -23.4% |
| 2020 | 1.74x | ₩18.79 Billion | ₩10.80 Billion | ₩6.40 Billion | ▲ +138.0% |
| 2019 | 0.73x | ₩5.09 Billion | ₩6.96 Billion | ₩2.36 Billion | ▼ -74.6% |
| 2018 | 2.87x | ₩8.14 Billion | ₩2.83 Billion | ₩2.67 Billion | ▲ +727.5% |
| 2013 | 0.35x | ₩2.76 Billion | ₩7.95 Billion | ₩2.24 Billion | ▼ -45.2% |
| 2011 | 0.63x | ₩3.97 Billion | ₩6.27 Billion | ₩3.68 Billion | ▼ -58.9% |
| 2010 | 1.54x | ₩4.13 Billion | ₩2.68 Billion | ₩3.95 Billion | — |